NCT01746342View on ClinicalTrials.gov

Sleep Apnea in Multiple Sclerosis Positive Airway Pressure Trial

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Obstructive Sleep Apnea-hypopnea in Multiple Sclerosis Patients
Interventions
DEVICE

Effective continuous positive airway pressure (CPAP)

DEVICE

Sham continuous positive airway pressure (CPAP)

Trial Locations (1)

H3A 1A1

McGill University Health Centre, Montreal

Sponsors

Collaborators (1)

Philips Respironics
All Listed Sponsors
collaborator

Multiple Sclerosis Society of Canada (Primary funding agency)

UNKNOWN

collaborator

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

collaborator

Philips Respironics

INDUSTRY

collaborator

VitalAire Incorporated (Respiratory Therapist time)

UNKNOWN

lead

McGill University

OTHER

NCT01746342 - Sleep Apnea in Multiple Sclerosis Positive Airway Pressure Trial | Biotech Hunter | Biotech Hunter